| pubmed-article:2292158 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2292158 | lifeskim:mentions | umls-concept:C0029925 | lld:lifeskim |
| pubmed-article:2292158 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
| pubmed-article:2292158 | lifeskim:mentions | umls-concept:C0085264 | lld:lifeskim |
| pubmed-article:2292158 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:2292158 | pubmed:dateCreated | 1991-4-11 | lld:pubmed |
| pubmed-article:2292158 | pubmed:abstractText | Radioimmunoscintigraphy with I-123 labeled monoclonal antibody HMFG1 has been used for imaging primary and metastatic ovarian neoplasms. Uptake of I-123 labeled HMFG1 is reported in a patient with an orbital metastasis from a primary ovarian adenocarcinoma. Radioimmunoscintigraphy may have a role to play in imaging metastatic orbital neoplasms. | lld:pubmed |
| pubmed-article:2292158 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2292158 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2292158 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2292158 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2292158 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2292158 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2292158 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:2292158 | pubmed:issn | 0363-9762 | lld:pubmed |
| pubmed-article:2292158 | pubmed:author | pubmed-author:BrittonK EKE | lld:pubmed |
| pubmed-article:2292158 | pubmed:author | pubmed-author:MatherS JSJ | lld:pubmed |
| pubmed-article:2292158 | pubmed:author | pubmed-author:GranowskaMM | lld:pubmed |
| pubmed-article:2292158 | pubmed:author | pubmed-author:BomanjiJJ | lld:pubmed |
| pubmed-article:2292158 | pubmed:author | pubmed-author:HungerfordJ... | lld:pubmed |
| pubmed-article:2292158 | pubmed:author | pubmed-author:GlaholmJJ | lld:pubmed |
| pubmed-article:2292158 | pubmed:author | pubmed-author:WhitelockeRR | lld:pubmed |
| pubmed-article:2292158 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2292158 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:2292158 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2292158 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2292158 | pubmed:pagination | 825-7 | lld:pubmed |
| pubmed-article:2292158 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2292158 | pubmed:meshHeading | pubmed-meshheading:2292158-... | lld:pubmed |
| pubmed-article:2292158 | pubmed:meshHeading | pubmed-meshheading:2292158-... | lld:pubmed |
| pubmed-article:2292158 | pubmed:meshHeading | pubmed-meshheading:2292158-... | lld:pubmed |
| pubmed-article:2292158 | pubmed:meshHeading | pubmed-meshheading:2292158-... | lld:pubmed |
| pubmed-article:2292158 | pubmed:meshHeading | pubmed-meshheading:2292158-... | lld:pubmed |
| pubmed-article:2292158 | pubmed:meshHeading | pubmed-meshheading:2292158-... | lld:pubmed |
| pubmed-article:2292158 | pubmed:meshHeading | pubmed-meshheading:2292158-... | lld:pubmed |
| pubmed-article:2292158 | pubmed:meshHeading | pubmed-meshheading:2292158-... | lld:pubmed |
| pubmed-article:2292158 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2292158 | pubmed:articleTitle | Radioimmunoscintigraphy of orbital metastases from ovarian carcinoma. | lld:pubmed |
| pubmed-article:2292158 | pubmed:affiliation | Department of Nuclear Medicine, St. Bartholomew's Hospital, London, United Kingdom. | lld:pubmed |
| pubmed-article:2292158 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2292158 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:2292158 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
